Products - Obesity | Topic | NICE

Showing 3 products

Date | Title

Status: Awaiting developmentRemove ‘Status: Awaiting development’ filter

Setmelanotide for treating acquired hypothalamic obesity in people 4 years and older [ID6542]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
10 February 2027
Retatrutide for managing overweight and obesity [ID6644]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Setmelanotide for treating obesity and hyperphagia in Bardet-Biedl syndrome (review of HST31) [ID6598]
Status:
Awaiting development
Programme:
Highly specialised technologies guidance
Expected publication date:
TBC